Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.457\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1csc(=O)n1CCC(=O)OCC(=O)Nc1ccc(C(N)=O)cc1
b Br.CCCCn1c(=N)n(CC(=O)C(C)(C)C)c2ccccc21
Answer: a. Cc1csc(=O)n1CCC(=O)OCC(=O)Nc1ccc(C(N)=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1csc(=O)n1CCC(=O)OCC(=O)Nc1ccc(C(N)=O)cc1
Cc1csc(=O)n1CCC(=O)OCC(=O)Nc1ccc(C(N)=O)cc1
[2-(4-carbamoylanilino)-2-oxoethyl] 3-(4-methyl-2-oxo-1,3-thiazol-3-yl)propanoate